Thrombospondin (TSP-1) Inhibitor, LSKL – 1 mg

Overview

The Thrombospondin (TSP-1) Inhibitor, LSKL, is a specialized peptide designed to inhibit the activation of TGF-ß by thrombospondin (TSP-1). Derived from the latency-associated peptide, this powerful inhibitor plays a crucial role in preventing hepatic damage and fibrosis, making it essential for researchers focused on liver pathology and related diseases.

Key Features

• Inhibits TGF-ß activation by TSP-1
• Derived from the latency-associated peptide
• Supports research in hepatic damage and fibrosis
• 1 mg of high-purity peptide per vial
• Easy handling and storage

Specifications

FAQ

What is the role of TSP-1 in the body?

Thrombospondin-1 (TSP-1) is a matricellular protein involved in various biological processes, including angiogenesis and tissue repair. It plays a significant role in the activation of TGF-ß, impacting fibrotic processes.

How do I store the LSKL peptide?

Store the Thrombospondin (TSP-1) Inhibitor, LSKL at -20°C to maintain its stability and efficacy. Avoid repeated freeze-thaw cycles to preserve the quality of the peptide.

Can LSKL be used in vivo studies?

Yes, LSKL is suitable for in vivo applications. Researchers often utilize this inhibitor to understand the mechanisms of fibrosis and potential therapeutic avenues for liver diseases.

Enhance your research today with the Thrombospondin (TSP-1) Inhibitor, LSKL. It’s a vital tool for your studies on hepatic health and fibrosis. Shop now to integrate this essential peptide into your investigative work.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.